trinity® software promap 4.3.0 (Koelis Inc)
90
Structured Review
Koelis Inc
trinity® software promap 4.3.0
Trinity® Software Promap 4.3.0, supplied by Koelis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trinity+software/trinity++software+promap+4+3+0/pm40566122-63-11-10
Average 90 stars, based on 1 article reviews
Trinity® Software Promap 4.3.0, supplied by Koelis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trinity+software/trinity++software+promap+4+3+0/pm40566122-63-11-10
Average 90 stars, based on 1 article reviews
trinity® software promap 4.3.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Magnetic Resonance Imaging:Article Title: Surgeon seniority and experience have no effect on CaP detection rates using MRI/TRUS fusion-guided targeted biopsies. Article Snippet: Objective: To determine (i) whether urologist seniority and experience are associated with prostate cancer (CaP) and clinically significant CaP (csCaP) detection rates using magnetic resonance imaging/ultrasound (MRI/US) fusion-guided targeted biopsies, taking multiparametric magnetic resonance imaging (mpMRI) as the reference standard, and (ii) if cancer detection rates (CDR) differ across regions of the prostate using Dickinson’s 27-sector map, regardless of seniority.. Methods: We retrospectively reviewed a consecutive series of patients with suspicion of prostate cancer who underwent targeted and systematic biopsies at 1 center by 1 of 7 urologists (2 seniors and 5 juniors) between January 1, 2016 and December 31, 2021, following positive mpMRI.. Results: The cohort comprised 403 patients (454 lesions) aged 67.7§6.8. Software:Article Title: Surgeon seniority and experience have no effect on CaP detection rates using MRI/TRUS fusion-guided targeted biopsies. Article Snippet: Objective: To determine (i) whether urologist seniority and experience are associated with prostate cancer (CaP) and clinically significant CaP (csCaP) detection rates using magnetic resonance imaging/ultrasound (MRI/US) fusion-guided targeted biopsies, taking multiparametric magnetic resonance imaging (mpMRI) as the reference standard, and (ii) if cancer detection rates (CDR) differ across regions of the prostate using Dickinson’s 27-sector map, regardless of seniority.. Methods: We retrospectively reviewed a consecutive series of patients with suspicion of prostate cancer who underwent targeted and systematic biopsies at 1 center by 1 of 7 urologists (2 seniors and 5 juniors) between January 1, 2016 and December 31, 2021, following positive mpMRI.. Results: The cohort comprised 403 patients (454 lesions) aged 67.7§6.8. |